Consider the clinicaltrials by which drugs are tested in…
“Consider the clinicaltrials by which drugs are tested in human subjects.5 Before a new drug can enter the market, its manufacturer must sponsor clinicaltrials to show the Food and Drug Administration that the drug is safe and effective, usually as compared with a placebo or dummy pill. The results of all the trials (there may be many) are submitted to the FDA, and if one or two trials are positive—that is, they show effectiveness without serious risk—the drug is usually approved, even if all the other trials are negative.”
About This Quote
This interpretation was drafted with AI assistance. It is one reading of the quote, not the author's own explanation.
Regulatory approval often relies on a few positive trials, overlooking many negative results, which can mislead about a drug’s true safety and efficacy.
In simple terms: Drugs may be approved despite many failed tests.
Key Takeaway
Demand more comprehensive evidence before approval.
Themes
medical ethics
regulation
pharmaceuticals
Mood
cautious
critical
Type
analytical
informative
When to use this quote
- healthcare decision making
- patient safety
- drug development
- regulatory review
Key Concepts
clinical trial bias
risk assessment
policy
Questions to Reflect On
- How can regulators ensure balanced evaluation?
- What safeguards protect patients from insufficient data?
A Different Perspective
A single positive result may not reflect overall drug performance.